Countdown to Ethereum Pectra Upgrade Activation: Learn more
$2.61T
Total marketcap
$243.52B
Total volume
BTC 60.53%     ETH 7.27%
Dominance

CBD Life Sciences CBDL Stock

0.0003 USD {{ price }} 0.000000% {{change_pct}}%
Market Cap
834.61K USD
LOW - HIGH [24H]
0.0003 - 0.0004 USD
VOLUME [24H]
12.33M USD
{{ volume }}
P/E Ratio
0
Earnings per share
0 USD

CBD Life Sciences Price Chart

CBD Life Sciences CBDL Financial and Trading Overview

CBD Life Sciences stock price 0.0003 USD
Previous Close 0 USD
Open 0.0004 USD
Bid 0.0004 USD x 0
Ask 0.0005 USD x 0
Day's Range 0.0004 - 0.0005 USD
52 Week Range 0.0003 - 0.03 USD
Volume 14.94M USD
Avg. Volume 38.94M USD
Market Cap 1.39M USD
Beta (5Y Monthly) 54.552
PE Ratio (TTM) N/A
EPS (TTM) 0 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

CBDL Valuation Measures

Enterprise Value 136.84K USD
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 7.795072
Price/Book (mrq) 0.25
Enterprise Value/Revenue 0.767
Enterprise Value/EBITDA -2.638

Trading Information

CBD Life Sciences Stock Price History

Beta (5Y Monthly) 54.552
52-Week Change -98.33%
S&P500 52-Week Change 23.80%
52 Week High 0.03 USD
52 Week Low 0.0003 USD
50-Day Moving Average 0.000484 USD
200-Day Moving Average 0.00225335 USD

CBDL Share Statistics

Avg. Volume (3 month) 38.94M USD
Avg. Daily Volume (10-Days) 14.13M USD
Shares Outstanding 2.78B
Float N/A
Short Ratio N/A
% Held by Insiders 0%
% Held by Institutions 0%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield NaN
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 1:300

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2023
Most Recent Quarter (mrq) March 31, 2024
Next Fiscal Year End December 31, 2024

Profitability

Profit Margin -60.20%
Operating Margin (ttm) -122.24%
Gross Margin 45.05%
EBITDA Margin -29.073%

Management Effectiveness

Return on Assets (ttm) N/A
Return on Equity (ttm) -45.076%

Income Statement

Revenue (ttm) 178.45K USD
Revenue Per Share (ttm) 0.001 USD
Quarterly Revenue Growth (yoy) 35.79%
Gross Profit (ttm) 80.41K USD
EBITDA -51880 USD
Net Income Avi to Common (ttm) -107437 USD
Diluted EPS (ttm) 0
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 82 USD
Total Cash Per Share (mrq) 0 USD
Total Debt (mrq) 0 USD
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 4.159
Book Value Per Share (mrq) 0.002

Cash Flow Statement

Operating Cash Flow (ttm) -19586 USD
Levered Free Cash Flow (ttm) N/A

Profile of CBD Life Sciences

Country United States
State AZ
City Scottsdale
Address 10855 N 116th Street
ZIP 85259
Phone 480 410 6780
Website https://lbcbioscienceinc.com
Industry Drug Manufacturers - Specialty & Generic
Sector(s) Healthcare
Full Time Employees 3

CBD Life Sciences Inc. engages in the development and marketing a line of cannabidiol based organic products. Its cannabidiol based organic products include hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, coffee, wine, skincare line, tablets, and a line of pet products. The company is based in Scottsdale, Arizona.

Q&A For CBD Life Sciences Stock

What is a current CBDL stock price?

CBD Life Sciences CBDL stock price today per share is 0.0003 USD.

How to purchase CBD Life Sciences stock?

You can buy CBDL shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for CBD Life Sciences?

The stock symbol or ticker of CBD Life Sciences is CBDL.

Which industry does the CBD Life Sciences company belong to?

The CBD Life Sciences industry is Drug Manufacturers - Specialty & Generic.

How many shares does CBD Life Sciences have in circulation?

The max supply of CBD Life Sciences shares is 2.78B.

What is CBD Life Sciences Price to Earnings Ratio (PE Ratio)?

CBD Life Sciences PE Ratio is now.

What was CBD Life Sciences earnings per share over the trailing 12 months (TTM)?

CBD Life Sciences EPS is 0 USD over the trailing 12 months.

Which sector does the CBD Life Sciences company belong to?

The CBD Life Sciences sector is Healthcare.